BIOQUÍMICA Y BIOLOGÍA MOLECULAR I
Departamento
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (23)
2023
-
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk
International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248
2022
-
Involvement of the PI3K/AKT Intracellular Signaling Pathway in the AntiCancer Activity of Hydroxytyrosol, a Polyphenol from Olea europaea, in Hematological Cells and Implication of HSP60 Levels in Its Anti-Inflammatory Activity
International Journal of Molecular Sciences, Vol. 23, Núm. 13
-
Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma
Clinical Epigenetics, Vol. 14, Núm. 1
2021
-
Genetically determined telomere length and multiple myeloma risk and outcome
Blood Cancer Journal, Vol. 11, Núm. 4
2020
-
Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL
Leukemia, Vol. 34, Núm. 10, pp. 2722-2735
-
Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms
Blood Cancer Journal, Vol. 10, Núm. 8
-
The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma
Oncotarget, Vol. 11, Núm. 13, pp. 1172-1185
2018
-
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients
British Journal of Haematology, Vol. 183, Núm. 3, pp. 375-384
-
The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
Molecular Therapy - Nucleic Acids, Vol. 13, pp. 16-28
2010
-
Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer
Journal of Pathology, Vol. 222, Núm. 1, pp. 89-98
2009
-
The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer
Human Molecular Genetics, Vol. 18, Núm. 7, pp. 1343-1352
2008
-
Erratum: Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer (Epigenetics vol. 3(2) (64-68))
Epigenetics
-
Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification
Journal of Pathology, Vol. 214, Núm. 3, pp. 347-356
-
Frequent BRG1/SMARCA4-Inactivating mutations in human lung cancer cell lines
Human Mutation, Vol. 29, Núm. 5, pp. 617-622
-
Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer
Epigenetics, Vol. 3, Núm. 2, pp. 64-68
2007
-
Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer
Oncogene, Vol. 26, Núm. 11, pp. 1616-1625
2006
-
Cannabinoid receptors as novel targets for the treatment of melanoma
FASEB Journal, Vol. 20, Núm. 14
-
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy
Journal of Clinical Oncology, Vol. 24, Núm. 26, pp. 4333-4339
2005
-
Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells
Human Molecular Genetics, Vol. 14, Núm. 7, pp. 973-982
2004
-
Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations
Oncogene, Vol. 23, Núm. 29, pp. 5084-5091